PDCD1 and neoplasm: In a mouse breast cancer model, intratumoral injection of reovirus increased PD-L1 expression on tumor cells, and combination reovirus/anti-PD-1 treatment significantly improved survival by reducing the number of regulatory T cells and enhancing tumor-specific cytotoxic T lymphocyte responses 106.